-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $4.5

Benzinga·05/15/2026 12:02:41
Listen to the news
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.25 to $4.5.